IP Library Granted Patent US 9,649,380
Granted Patent B2
US 9,649,380 · App. 13/179,712 · Granted May 16, 2017

Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin

Inventors: Valeria Longoni (Latina, IT); Marisa Penci (Latina, IT)
Assignee: Pfizer Italia S.R.L.
A61K47/02A23L33/135A23L33/16A23L33/19A23L33/21A61K9/0095A61K35/745A61K35/747A61K38/063A61K38/40A61K47/183A61K47/26A61K47/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,649,380
App. No.
13/179,712
Granted
May 16, 2017
Kind
B2
Abstract

The present invention relates to compositions comprising probiotic and prebiotic components, mineral salts, lactoferrin, and possibly saccharomycetes, which perform correct, effective colonisation of the probiotic components administered, with enteric consequences which involve maintaining and/or restoring intestinal health and preventing the consequences of common dysbioses of the digestive tract caused by stress, incorrect dietary habits and antibiotic treatments. Said compositions also have a concomitant anti-inflammatory and immunomodulating action.

Claims (10)

1. A probiotic composition for oral administration, comprising:

a) at least about 50 billion CFU/g Bifidobacterium longum R175;

b) at least about 150 billion CFU/g Lactobacillus helveticus R52;

c) at least about 150 billion CFU/g Lactobacillus plantarum R1012;

d) one or more prebiotic components selected from inulin, fructose, fructooligosaccharides and mixtures thereof;

e) lactoferrin

f) one or more metal salts selected from the group consisting of magnesium gluconate, potassium citrate, copper citrate and zinc gluconate;

g) optionally glutathione; and

h) one or more excipients.

2. A probiotic composition for oral administration, comprising (a) probiotics in an amount of at least about: Bifidobacterium longum 50 billion CFU/g; Lactobacillus helveticus 150 billion CFU/g; and Lactobacillus plantarum 150 billion CFU/g, (b) one or more prebiotic components selected from inulin, fructose, fructooligosaccharides and mixtures thereof, (c) lactoferrin, (d) one or more metal salts selected from magnesium gluconate, potassium citrate, zinc gluconate, and copper citrate, (e) optional glutathione and (f) excipients.

Assignments (5)
CHANGE OF NAME Recorded Apr 28, 2025
From: GLAXOSMITHKLINE CONSUMER HEALTHCARE S.R.L.
To: HALEON ITALY S.R.L.
Reel/Frame 070957/0762 →
MERGER AND CHANGE OF NAME Recorded Sep 12, 2023
From: PFIZER CONSUMER HEALTHCARE ITALY S.R.L.; GLAXOSMITHKLINE CONSUMER HEALTHCARE S.R.L.
To: GLAXOSMITHKLINE CONSUMER HEALTHCARE S.R.L.
Reel/Frame 064872/0323 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2019
From: PFIZER ITALIA S.R.L.
To: PFIZER CONSUMER HEALTHCARE ITALY S.R.L.
Reel/Frame 049862/0758 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2012
From: WYETH LLC
To: PFIZER ITALIA S.R.L.
Reel/Frame 027870/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2012
From: LONGONI, VALERIA; PENCI, MARISA
To: WYETH LLC
Reel/Frame 027840/0318 →
Priority Claims (1)
IT MI2009A0019 · Jan 12, 2009 · national
Continuity (1)
Related Publication 20120207712A1 · Aug 16, 2012